Literature DB >> 8980130

VASP interaction with vinculin: a recurring theme of interactions with proline-rich motifs.

M Reinhard1, M Rüdiger, B M Jockusch, U Walter.   

Abstract

VASP (vasodilator-stimulated phosphoprotein), a protein associated with microfilaments at cellular contact sites, has been identified as a ligand for profilin and zyxin, two proteins also involved in microfilament dynamics and organization at these regions. Here, we report that VASP also directly binds to vinculin, another component of adherens junctions. Competition experiments with a vinculin-derived peptide showed that a proline-rich motif, located in the hinge region that connects vinculin's head and tail domains, is involved in VASP binding. The same motif is present in zyxin but the interactions of VASP with vinculin and zyxin differ in detail. Hence, this motif may be recognized by VASP in different ways when presented in distinct cellular sites.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980130     DOI: 10.1016/s0014-5793(96)01295-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  39 in total

1.  LPP, an actin cytoskeleton protein related to zyxin, harbors a nuclear export signal and transcriptional activation capacity.

Authors:  M M Petit; J Fradelizi; R M Golsteyn; T A Ayoubi; B Menichi; D Louvard; W J Van de Ven; E Friederich
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

Review 2.  Actin-based motility of intracellular microbial pathogens.

Authors:  M B Goldberg
Journal:  Microbiol Mol Biol Rev       Date:  2001-12       Impact factor: 11.056

3.  Dual epitope recognition by the VASP EVH1 domain modulates polyproline ligand specificity and binding affinity.

Authors:  L J Ball; R Kühne; B Hoffmann; A Häfner; P Schmieder; R Volkmer-Engert; M Hof; M Wahl; J Schneider-Mergener; U Walter; H Oschkinat; T Jarchau
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

4.  FoxO1a-cyclic GMP-dependent kinase I interactions orchestrate myoblast fusion.

Authors:  Philippe R J Bois; Vanessa F Brochard; Adèle V A Salin-Cantegrel; John L Cleveland; Gerard C Grosveld
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

5.  Development of small molecules designed to modulate protein-protein interactions.

Authors:  Ye Che; Bernard R Brooks; Garland R Marshall
Journal:  J Comput Aided Mol Des       Date:  2006-04-19       Impact factor: 3.686

6.  A novel proline-rich motif present in ActA of Listeria monocytogenes and cytoskeletal proteins is the ligand for the EVH1 domain, a protein module present in the Ena/VASP family.

Authors:  K Niebuhr; F Ebel; R Frank; M Reinhard; E Domann; U D Carl; U Walter; F B Gertler; J Wehland; T Chakraborty
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

7.  Neural Wiskott-Aldrich syndrome protein is implicated in the actin-based motility of Shigella flexneri.

Authors:  T Suzuki; H Miki; T Takenawa; C Sasakawa
Journal:  EMBO J       Date:  1998-05-15       Impact factor: 11.598

8.  Tension-sensitive actin assembly supports contractility at the epithelial zonula adherens.

Authors:  Joanne M Leerberg; Guillermo A Gomez; Suzie Verma; Elliott J Moussa; Selwin K Wu; Rashmi Priya; Brenton D Hoffman; Carsten Grashoff; Martin A Schwartz; Alpha S Yap
Journal:  Curr Biol       Date:  2014-07-24       Impact factor: 10.834

Review 9.  Molecular and cellular mechanisms of invasion of the intestinal barrier by enteric pathogens. The paradigm of Shigella.

Authors:  P J Sansonetti
Journal:  Folia Microbiol (Praha)       Date:  1998       Impact factor: 2.099

10.  NOX4 (NADPH Oxidase 4) and Poldip2 (Polymerase δ-Interacting Protein 2) Induce Filamentous Actin Oxidation and Promote Its Interaction With Vinculin During Integrin-Mediated Cell Adhesion.

Authors:  Sasa Vukelic; Qian Xu; Bonnie Seidel-Rogol; Elizabeth A Faidley; Anna E Dikalova; Lula L Hilenski; Ulrich Jorde; Leslie B Poole; Bernard Lassègue; Guogang Zhang; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.